Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | ADMAAdma Biologics, Inc.FY2025 · Dec |
|---|---|
| Revenue | $510.17M |
| Revenue, yoy | +19.6% |
| Net income | $146.93M |
| Net income, yoy | −25.7% |
| Net margin | 28.8% |
| Free cash flow | $27.82M |
| FCF margin | 5.5% |
| EPS, diluted | $0.60 |
Add another company.